Zoltán Rátkai

Title: Zoltán Rátkai: Innovator in Pharmaceutical Chemistry

Introduction

Zoltán Rátkai is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that showcase his innovative approaches to drug development.

Latest Patents

Rátkai's latest patents include a process for the preparation of a 3(2H)-pyridazinone-4-substituted amino 5-chloro derivative. This invention relates to novel processes for synthesizing 5-chloro-4-{3-[N-{2-(3,4-dimethoxyphenyl)-ethyl}-N-methylamino]}-propylamino-3(2H)pyridazinone and its pharmaceutically acceptable acid addition salts. An important feature of this invention is the use of 3,4,5-trichloropyridazone as the starting substance for the synthesis. Another notable patent involves 8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, which act as AMPA/kainate receptor inhibitors. This disclosure relates to a novel compound of formula I, along with a process for its preparation and a pharmaceutical composition containing it. The compounds possess unique competitive AMPA/kainate antagonist properties, making them useful in treating diseases where inhibition of these receptors may have a favorable effect.

Career Highlights

Zoltán Rátkai is currently associated with Egis Gyógyszergyár Rt., a leading pharmaceutical company in Hungary. His work focuses on developing innovative solutions that address critical health challenges through advanced chemical processes.

Collaborations

Rátkai has collaborated with notable colleagues such as Gyula Simig and József Barkóczy. Their combined expertise has contributed to the successful development of various pharmaceutical innovations.

Conclusion

Zoltán Rátkai's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in drug development and treatment options.